Frequency Electronics, Inc. (NASDAQ: FEIM) Exceeds Expectations with Strong Q1 2027 Earnings and Revenue Growth

• Strong EPS Beat: Frequency Electronics, Inc. reported earnings per share of $0.41, significantly beating the analyst consensus estimate of $0.15.
• Record Revenue Growth: The company achieved record revenue of $23.50 million in Q1 FY2027, a 70% increase year-over-year, driven by strong performance in its satellite and government programs.
• Robust Financial Health & Backlog: Frequency Electronics, Inc. boasts a strong current ratio of 6.95 and a record funded backlog of $129.00 million, indicating substantial future revenue potential.

Frequency Electronics, Inc. (NASDAQ: FEIM) is a company that designs and manufactures high-precision time and frequency control products. These products are critical for the operation of satellite, terrestrial, and airborne systems. Its main customers include the U.S. government and defense programs, which rely on its technology for communication and navigation.

On September 10, 2026, FEIM reported its quarterly earnings. The company announced an impressive earnings per share of $0.41. This figure significantly surpassed the analyst consensus estimate, which was set at only $0.15 per share, indicating a strong performance that exceeded market expectations for profitability.

The company also posted record revenue of $23.50 million for its first fiscal quarter of 2027, beating the estimated $17.85 million. As reported by GlobeNewswire, this represents a substantial 70% increase from the previous year. This growth is primarily driven by strong performance in its satellite and U.S. government programs.

This performance provides "increasing confidence in our ability to meet or exceed the $150.00 million or more in annual revenue," according to CEO Tom McClelland. The company also achieved a record funded backlog of $129.00 million, an 82% increase year-over-year. The backlog represents future revenue that is already under contract.

FEIM shows strong short-term financial health with a current ratio of 6.95. The current ratio measures a company's ability to pay its short-term obligations, with a higher number suggesting better liquidity. The company also has a price-to-sales ratio of 8.41, which compares its stock price to its revenues.